China takes strong measures to ensure affordable medicines during 14th Five-Year Plan period
During the 14th Five-Year Plan period (2021-2025), China’s medical insurance authority adopted multiple measures to ensure reasonable pricing of medicines,…
Production capacity boost: Haleon plans to ramp up investment in Pakistan
Haleon has planned to ramp up its investment in Pakistan with an initial outlay of $12 million, aimed at expanding…
Pakistan’s Pharma sector: SIFC backs deregulation as exports surge
The Special Investment Facilitation Council (SIFC) endorsed the government’s deregulation policy for pharmaceutical sector announced in February 2024, stating that…